Abstract
The role of adipocytes as protein secreting cells has been known for almost 15 years. Most of these proteins have known biological activity and are called adipokines. However, only a few of the adipokines have been shown to regulate insulin sensitivity. The latter effects are direct or indirect. The adipokines regulating insulin sensitivity are tumor necrosis factor alpha, adiponectin, interleukin-6, resistin and leptin. This review examines the mechanism how these adipokines influence insulin sensitivity, how the adipocyte production of the adipokines is regulated and if genetic variance in the genes encoding for adipokines is important for the development of type 2 diabetes mellitus.
Keywords: adipose tissue, endothelial cells, tumor necrosis factor alpha, glucose metabolism, gi protein, lipolytic, interleukin, glucocorticoids, inflammatory genes, single nucleotide polymorphisms
Current Molecular Medicine
Title: Insulin Resistance in Type 2 Diabetes - Role of the Adipokines
Volume: 5 Issue: 3
Author(s): P. Arner
Affiliation:
Keywords: adipose tissue, endothelial cells, tumor necrosis factor alpha, glucose metabolism, gi protein, lipolytic, interleukin, glucocorticoids, inflammatory genes, single nucleotide polymorphisms
Abstract: The role of adipocytes as protein secreting cells has been known for almost 15 years. Most of these proteins have known biological activity and are called adipokines. However, only a few of the adipokines have been shown to regulate insulin sensitivity. The latter effects are direct or indirect. The adipokines regulating insulin sensitivity are tumor necrosis factor alpha, adiponectin, interleukin-6, resistin and leptin. This review examines the mechanism how these adipokines influence insulin sensitivity, how the adipocyte production of the adipokines is regulated and if genetic variance in the genes encoding for adipokines is important for the development of type 2 diabetes mellitus.
Export Options
About this article
Cite this article as:
Arner P., Insulin Resistance in Type 2 Diabetes - Role of the Adipokines, Current Molecular Medicine 2005; 5 (3) . https://dx.doi.org/10.2174/1566524053766022
DOI https://dx.doi.org/10.2174/1566524053766022 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intratubular Renin-Angiotensin System in Hypertension
Current Hypertension Reviews Withdrawal Notice: Burden of Thyroid Dysfunction on Type 2 Diabetes Mellitus Patients with Emphasis on its Prevalence and Pattern of Presentation: A Case Controlled Study
Current Diabetes Reviews Calcium Intake Requirements Along the Life Cycle and Associated Factors
Current Nutrition & Food Science Diabetes, Sexual Dysfunction and Therapeutic Exercise: A 20 Year Review
Current Diabetes Reviews Boosting Interleukin-10 Production: Therapeutic Effects and Mechanisms
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Chymase Inhibitors
Current Pharmaceutical Design Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design Vitamin D and Cardiovascular Disease
Current Vascular Pharmacology Upregulated Retinol Binding Protein and Transthyretin as Predictive Biomarkers of Gestational Diabetes Mellitus
Current Proteomics Combinatorial Protein Biochemistry for Therapeutics and Proteomics
Current Pharmaceutical Biotechnology Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis
Current Drug Safety Effects of Oral and Non-Insulin Injectable Antidiabetic Treatment in Hypertension: A Systematic Review
Current Pharmaceutical Design The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapy Based on the Regulation of Thiol-dependent Redox Systems
Current Medicinal Chemistry Growth Hormone and Insulin-Like Growth Factor-I as an Endocrine Axis in Alzheimers Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Type 2 Diabetes, Insulin Secretion and β-Cell Mass
Current Molecular Medicine Soybean and Processed Soy Foods Ingredients, and Their Role in Cardiometabolic Risk Prevention
Recent Patents on Food, Nutrition & Agriculture Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction
Current Medicinal Chemistry Mitochondrial Involvement in Psychiatric Illness in Adults
Current Psychiatry Reviews